1-3 of 3
Srikant Viswanadha, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual PI3Kδ/γ Inhibition By RP6530 Induces Apoptosis and Cytotoxicity In B-Lymphoma Cells

Swaroop Vakkalanka, PhD, Srikant Viswanadha, Ph.D., Eugenio Gaudio, PhD, Emanuele Zucca, MD, Francesco Bertoni, MD, Elena Bernasconi, B.Sc., Davide Rossi, MD, Ph.D., Anastasios Stathis, MD
Journal: Blood
Blood (2013) 122 (21): 4411.
https://doi.org/10.1182/blood.V122.21.4411.4411
Published: 2013
Journal Articles

RP6530, a Dual PI3Kδ/γ Inhibitor, Attenutates AKT Phosphorylation and Induces Apoptosis In Primary Cutaneous T Cell Lymphoma (CTCL) Cells

Julia Lewis, Ph.D, Michael Girardi, MD, FAAD, Swaroop Vakkalanka, PhD, Srikant Viswanadha, Ph.D., Francesco Bertoni, MD
Journal: Blood
Blood (2013) 122 (21): 4418.
https://doi.org/10.1182/blood.V122.21.4418.4418
Published: 2013
Journal Articles

The PI3K Delta Inhibitor TGR-1202 and Proteasome Inhibitor Carfilzomib Are Highly Synergistic In Killing Human B- and T-Cell Lymphoma Cells

Changchun Deng, M.D, PH.D., Christine McIntosh, Richard Rodriguez, B.S., Peter Sportelli, Hari P. Miskin, MS, Swaroop Vakkalanka, PhD, Srikant Viswanadha, Ph.D., Mark Lipstein, B.S., Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4421.
https://doi.org/10.1182/blood.V122.21.4421.4421
Published: 2013